Surna Cultivation Technologies Signs $2.1 Million Contract
This is the 4th Multi-Million Contract Awarded in the Last Couple Years, With Three in 2022 Alone!
LIVE CHART
An Additional Multi-Million Dollar Contract Signed for HVACD Systems
Louisville, Colorado, March...
Adding CEA Industries (CEAD) $2.05 to Watch List.
Formerly Surna (SRNA), Name Changed, Symbol Changed and $24 Million Raised.
LIVE CHART
A number of new issues have been tumbling after their IPO or Secondary...
Glutathione: The “Mother” of all Antioxidants…
Glutathione, also known as GSH, is a molecule found naturally in your body. It is produced by the liver and nerve cells in the...
Revive Therapeutics (RVVTF) Regulatory Update Archive.
April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...
Stand Down. “A Super Bubble” says Jeremy Grantham, the “Day of Reckoning is Here”...
Calling a Super Bubble. | Front Row with Jeremy Grantham
https://youtu.be/JlEGU2ypr1Q
The Day of Reckoning is Here. Stagflation Will Shock the Markets! | Peter Schiff
https://youtu.be/_c6Fv4BM-8c
Fun (or...
Revive Therapeutics (RVVTF, RVV): Updates and News Archive.
Recent Headlines
(See FDA Filing Submission at Bottom)
LIVE QUOTE
NEWS ARCHIVE INTRO
“These medicines have a sweet spot. If the day you get diagnosed with COVID you...
Amazing Sales of Paxlovid (CBS News).
"These medicines have a sweet spot. If the day you get diagnosed COVID you say 'forget it, I'll be fine,' and then several days...
Our Best Risk to Reward Idea Ever?
Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 Pack, 12 Biotech Stocks We Expect to Double" Watch List*.
If not our best ever,...
ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.
Demonstrates 100% Completion of Planned Treatment Cycles.
Immix Biopharma, Inc. Wed, January 19, 2022.
ImmixBio Announces Positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data Demonstrating...
Revive Therapeutics Updates, on Phase III Clinical Trial!
Michael Frank, CEO of the Company commented, "We are now in the final stages in our Phase 3 study.."
Revive Therapeutics Provides Update on...
Latest article
Who’s the Next Eric Sprott?
To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...
Perpetua (PPTA) Raises $300 Million.
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
Brixton Metals (BBBXF) $0.072, Leaps 62%. On No News.
Institutional Gold Analyst
It's always fun to decide on a single word, to describe a 62% single day price gain. Should we use "rose, surged,...
